Serum‐Level Changes of Vascular Endothelial Growth Factor in Children with Infantile Hemangioma after Oral Propranolol Therapy
- 5 August 2013
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
- Vol. 30 (5), 549-553
- https://doi.org/10.1111/pde.12192
Abstract
Oral propranolol is the first-line therapy for infantile hemangioma (IH), but its mechanism of action remains unclear. The aim of this study was to evaluate the change in serum vascular endothelial growth factor (VEGF) levels in patients with IH who underwent propranolol treatment. The study included 22 patients with IH receiving propranolol treatment. At three time points-before treatment and 1 and 3 months after treatment-blood samples were examined by enzyme-linked immunosorbent assay for serum VEGF expression. The mean serum VEGF concentration in children with proliferative hemangiomas was 395.0 ± 176.7 pg/mL, approximately twice as high as in patients with venous malformations (mean 170.7 pg/mL) and in healthy controls (204.8 pg/mL, p = 0.006). After 1 month of propranolol treatment, the level had fallen 21.6% (p = 0.003), although the downward trend was less obvious after 3 months of treatment (18.0%, p = 0.63). VEGF expression correlated significantly with the lesion size (correlation coefficient [R] = 0.43, p = 0.046), whereas no correlation was observed with age (R = 0.13, p = 0.56). Serum VEGF levels were higher in patients with IH and fell after 1 month of oral propranolol treatment. Similar results, although less pronounced, were found after 3 months of treatment. Lesion volume and serum level of VEGF were significantly correlated.Keywords
This publication has 17 references indexed in Scilit:
- Recurrence of Infantile Hemangiomas Treated with PropranololPediatric Dermatology, 2011
- Efficacy and safety of propranolol as first-line treatment for infantile hemangiomasEuropean Journal of Pediatrics, 2010
- Propranolol for infantile haemangiomas: insights into the molecular mechanisms of actionBritish Journal of Dermatology, 2010
- Local serum levels of vascular endothelial growth factor in infantile hemangioma: Intriguing mechanism of endothelial growthCytokine, 2010
- Serum Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Children with Hemangiomas and Vascular Malformations—Preliminary ReportPediatric Dermatology, 2009
- Propranolol for Severe Hemangiomas of InfancyThe New England Journal of Medicine, 2008
- Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical LiteraturePediatric Dermatology, 2008
- Hypoxia-Induced Mediators of Stem/Progenitor Cell Trafficking Are Increased in Children With HemangiomaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Oral Corticosteroid Use Is Effective for Cutaneous HemangiomasArchives of Dermatology, 2001
- Cellular markers that distinguish the phases of hemangioma during infancy and childhood.JCI Insight, 1994